{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T02:08:52Z","timestamp":1789697332169,"version":"4.0.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Hematol Oncol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Thrombocytopenia occurs in 60% of patients with myelodysplastic syndromes (MDS), increasing the risk of life-threatening haemorrhage in this population of mainly old patients with comorbidities. However, data are scare regarding immune thrombocytopenia (ITP) secondary to MDS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Aim<\/jats:title>\n                <jats:p>We analyzed the utility of indium-111 platelet scintigraphy (IPS) to better characterize the mechanisms of thrombocytopenia in 21 adult patients with MDS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Adult patients with a definite diagnosis of MDS according to the international criteria who underwent IPS between 2009 and 2018 because of an increased bleeding risk were retrospectively selected. Autologous 111Indium platelet labelling was performed with a technique similar to that described previously using a standardized method.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Platelet lifespan \u2264 6 days identified patients with peripheral platelet destruction. Taking into account the response to ITP-directed therapies after IPS, the sensitivity, specificity, and positive and negative predictive values of IPS were 100%, 84.6%, 80%, and 100%, respectively. <\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We show that IPS can be a useful tool to identify the mechanism and guide treatment of a chronic thrombocytopenia increasing the bleeding risk in patients with MDS. <\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40164-023-00414-1","type":"journal-article","created":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T04:01:53Z","timestamp":1685419313000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Utility of indium-111 platelet scintigraphy for understanding the mechanism of thrombocytopenia associated with myelodysplastic syndromes and chronic myelomonocytic leukemia"],"prefix":"10.1186","volume":"12","author":[{"given":"Pauline","family":"Durand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Pottier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Mesguich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Debordeaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estibaliz","family":"Lazaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Viallard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0254-3394","authenticated-orcid":false,"given":"Etienne","family":"Rivi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,30]]},"reference":[{"issue":"9","key":"414_CR1","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1002\/cncr.22602","volume":"109","author":"H Kantarjian","year":"2007","unstructured":"Kantarjian H, Giles F, List A, et al. The incidence and impact of thrombocytopenia in myelodysplastic syndromes. Cancer. 2007;109(9):1705\u201314.","journal-title":"Cancer"},{"issue":"5","key":"414_CR2","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.3324\/haematol.2020.272559","volume":"106","author":"V Jachiet","year":"2021","unstructured":"Jachiet V, Moulis G, Hadjadj J, et al. Clinical spectrum, outcome and management of immune thrombocytopenia associated with myelodysplastic syndromes and chronic myelomonocytic leukemia. Haematologica. 2021;106(5):1414\u201322.","journal-title":"Haematologica"},{"issue":"3","key":"414_CR3","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/leu.2015.297","volume":"30","author":"W Li","year":"2016","unstructured":"Li W, Morrone K, Kambhampati S, et al. Thrombocytopenia in MDS: epidemiology, mechanisms, clinical consequences and novel therapeutic strategies. Leukemia. 2016;30(3):536\u201344.","journal-title":"Leukemia"},{"issue":"11","key":"414_CR4","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","volume":"113","author":"F Rodeghiero","year":"2009","unstructured":"Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113(11):2386\u201393.","journal-title":"Blood"},{"issue":"9","key":"414_CR5","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1182\/blood-2004-06-2108","volume":"105","author":"E Houwerzijl","year":"2005","unstructured":"Houwerzijl E, Blom N, van der Want JVD, et al. Increased peripheral platelet destruction and caspase-3-independent programmed cell death of bone marrow megakaryocytes in myelodysplastic patients. Blood. 2005;105(9):3472\u20139.","journal-title":"Blood"},{"issue":"2\u20133","key":"414_CR6","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1159\/000206035","volume":"76","author":"A Efira","year":"1986","unstructured":"Efira A, Cauchie P, Rauis M, de Maertelaere E. Platelet survival in myelodysplastic syndromes. Acta Haematol. 1986;76(2\u20133):124\u20136.","journal-title":"Acta Haematol"},{"issue":"9","key":"414_CR7","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1111\/j.1538-7836.2006.02091.x","volume":"4","author":"M Kuwana","year":"2006","unstructured":"Kuwana M, Kurata Y, Fujimura K, et al. Preliminary laboratory based diagnostic criteria for immune thrombocytopenic purpura: evaluation by multi-center prospective study. J Thromb Haemost JTH. 2006;4(9):1936\u201343.","journal-title":"J Thromb Haemost JTH"},{"issue":"4","key":"414_CR8","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/bjh.14628","volume":"177","author":"A Cybulska","year":"2017","unstructured":"Cybulska A, Meintker L, Ringwald J, Krause SW. Measurements of immature platelets with haematology analysers are of limited value to separate immune thrombocytopenia from bone marrow failure. Br J Haematol. 2017;177(4):612\u20139.","journal-title":"Br J Haematol"},{"issue":"3","key":"414_CR9","doi-asserted-by":"publisher","first-page":"e847","DOI":"10.1097\/HS9.0000000000000847","volume":"7","author":"C Dussiau","year":"2023","unstructured":"Dussiau C, Dupuy H, Bidet A, Sauvezie M, De-Grande AC, Boureau L, et al. Impact of mutational status and prognostic factors on survival in chronic myelomonocytic leukemia with systemic inflammation and autoimmune disorders. HemaSphere. 2023;7(3):e847. https:\/\/doi.org\/10.1097\/HS9.0000000000000847.","journal-title":"HemaSphere"},{"issue":"3","key":"414_CR10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4999\/uhod.14397","volume":"30","author":"M Albayrak","year":"2014","unstructured":"Albayrak M, Eliacik E, Korucu B, et al. An immune thrombocytopenic purpura-like picture preceding chronic myelomonocytic leukemia: a case series and review of the literature. Int J Hematol Oncol. 2014;30(3):213\u20136.","journal-title":"Int J Hematol Oncol"}],"container-title":["Experimental Hematology &amp; Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40164-023-00414-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40164-023-00414-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40164-023-00414-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T04:06:04Z","timestamp":1685419564000},"score":1,"resource":{"primary":{"URL":"https:\/\/ehoonline.biomedcentral.com\/articles\/10.1186\/s40164-023-00414-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,30]]},"references-count":10,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["414"],"URL":"https:\/\/doi.org\/10.1186\/s40164-023-00414-1","relation":{},"ISSN":["2162-3619"],"issn-type":[{"value":"2162-3619","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,30]]},"assertion":[{"value":"5 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients gave informed consent and study was approved by our local IRB.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients gave consent for publication (non-opposition).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"50"}}